ArticleAtypical Localized Scleroderma Development During Nivolumab Therapy for Metastatic Lung AdenocarcinomaAuthor:Emma Fixsen, MDPublish date: October 20, 2022Immune checkpoint inhibitors such as nivolumab, a programmed cell death protein 1 (PD-1) inhibitor, are associated with immune-related adverse even...Read More
